MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
about
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingDifferences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screeningAdenoid cystic carcinoma: emerging role of translocations and gene fusionsGenetic alterations in salivary gland cancers.Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting.A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.Immunohistochemical and molecular profile of salivary gland cancer in children.Genomics of mucoepidermoid and adenoid cystic carcinomas.Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma
P2860
Q26781643-CE381DDC-23FC-49FF-AC46-9335738586CAQ35880030-939770AB-E0D6-4671-A68D-4237CE7F39BBQ36992178-BB4CCABB-4C46-4084-BB4D-35B3DDAD694AQ37662396-AEA7065D-B332-40F8-8B24-66621702F4BBQ38755879-4FE0C2D3-03E5-4557-8946-A10E4462E34FQ38820509-AE5795A0-776B-484F-84EF-AA045BBC79CDQ41194627-4913D5B9-D126-45B1-9FE6-C712B54C990DQ48307548-9C24F782-1B6D-4436-9572-557EF0A027E1Q49832806-9BB2DFE7-1309-4F01-B6FA-3643FCC648D6Q50030418-146FF1EE-8806-4E59-AE66-0DF0B1FA027CQ50884067-F6174D59-42EA-4206-B076-781AE592389CQ54129929-19002B0F-D731-4FEE-B973-77691CD0A8B7Q54963200-388557C8-2ACB-4563-A466-5FA934FC422CQ55004879-9C0F8D0A-D70F-41DF-A05D-EFBA5A296DA1Q58751739-5EF4DCF8-07F1-4A86-8919-43CED7108099
P2860
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@ast
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@en
type
label
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@ast
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@en
prefLabel
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@ast
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@en
P2093
P2860
P356
P1433
P1476
MYB rearrangement and clinicop ...... neck adenoid cystic carcinoma.
@en
P2093
Carole Fakhry
Eleni M Rettig
Justin A Bishop
Marietta Tan
Patrick K Ha
Raluca Yonescu
Shizhang Ling
P2860
P304
P356
10.1002/LARY.25356
P407
P577
2015-05-11T00:00:00Z